Empaone-M IR 12.5/500 Tablet

Empaone-M IR 12.5/500 Tablet is a prescription diabetes medicine that combines empagliflozin 12.5 mg and metformin 500 mg in each tablet. It belongs to the SGLT2 inhibitor + biguanide class and is used along with diet and exercise to help improve blood sugar control in adults with type 2 diabetes. The 10-tablet pack is made by MSN Laboratories and is intended for patients who need this specific combination and immediate-release tablet form. It is not for type 1 diabetes or for treating diabetic ketoacidosis.

How it works: Empagliflozin helps your kidneys remove extra sugar through urine, which lowers blood glucose. Metformin lowers the amount of sugar your liver makes and helps your body use insulin better, and this tablet combines both actions in one oral dose.

Empaone-M IR 12.5/500 Tablet is a mid-strength immediate-release option, with a lower metformin dose than the higher-strength Empaone-M ER 25/1000 Tablet. A doctor may choose this strength when a patient needs the empagliflozin-metformin combination but should start with a gentler metformin amount or needs a tablet that works faster than an extended-release form. Compared with ER products, this IR tablet is typically taken more than once daily and may cause stomach side effects sooner after dosing.

• Type 2 diabetes mellitus
• Improving blood sugar control
• Add-on treatment with diet and exercise
• May help reduce the need for separate diabetes tablets

• Swallow Empaone-M IR 12.5/500 Tablet whole with water; do not crush, split, or chew unless your doctor says it is okay.
• Take it exactly as prescribed, usually with meals to help reduce stomach upset from metformin.
• Take it at the same times each day so your blood sugar control stays steady.
• If you miss a dose, take it when you remember unless it is almost time for the next dose; do not double up.
• Drink enough fluids unless your doctor has told you to restrict fluids, because empagliflozin can increase urination.
• Follow your meal plan, exercise plan, and blood sugar checks while using this tablet.

Each Empaone-M IR 12.5/500 Tablet provides empagliflozin 12.5 mg plus metformin 500 mg per tablet. The usual frequency is determined by the prescriber, but immediate-release combinations like this are often taken more than once daily; the exact schedule and maximum daily tablet count depend on your kidney function, blood sugar response, and other medicines. Your doctor decides whether this strength is appropriate and adjusts the total daily dose based on safety and glucose control.

Do not change your dose or stop the medicine without speaking to your doctor.

Common side effects of Empagliflozin + Metformin may include:

• Nausea
• Diarrhea
• Stomach upset or abdominal pain
• Gas or bloating
• Decreased appetite
• Increased urination
• Genital yeast infection or itching, which may be more likely because of the empagliflozin component

• Do not use if you have type 1 diabetes or diabetic ketoacidosis.
• This is a higher-dose combination tablet than some starting regimens, so stomach upset, dehydration, and low blood sugar risk can be more noticeable when you first start or when your dose is changed.
• Use caution if you have kidney disease, liver disease, heart failure, or a history of dehydration.
• Limit alcohol, because heavy drinking raises the risk of lactic acidosis with metformin.
• Tell your clinician if you are fasting, on a low-carb diet, ill with fever or vomiting, or having surgery, because this medicine may need to be paused.
• Seek advice before driving or operating machinery if you feel dizzy, weak, or unwell.
• Monitor for low blood sugar if you also take insulin or a sulfonylurea.

• Insulin and sulfonylureas, which can increase the risk of low blood sugar
• Diuretics, which can worsen dehydration and low blood pressure
• Alcohol, which increases the risk of lactic acidosis with metformin
• Iodinated contrast dye used in some imaging tests, which may require temporary stopping
• Certain medicines that affect kidney function or fluid balance, including NSAIDs in some patients

Store Empaone-M IR 12.5/500 Tablet at room temperature in its original strip/box, away from excess heat, moisture, and direct light.